市場調査レポート
商品コード
1410846
頸動脈および腎動脈ステント市場:市場規模(セグメント別)、シェア、規制、償還、手技、予測(~2033年)Carotid and Renal Artery Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
頸動脈および腎動脈ステント市場:市場規模(セグメント別)、シェア、規制、償還、手技、予測(~2033年) |
出版日: 2023年12月21日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
頸動脈狭窄症には3種類の治療法が推奨されています。薬物療法、血管内治療、内膜剥離術です。
内膜剥離術は、狭窄症(70%以上)に罹患し、過去6ヵ月から1年間症状がある患者には、ステント留置術よりも推奨されます。頸動脈の狭窄が50%以下の患者には勧められません。血管内治療は頸動脈狭窄症の治療に利用できる新しい選択肢です。血管内治療はステントを用いて患部の動脈を開く低侵襲の治療法です。一方、RASは主に動脈硬化性腎動脈狭窄症(ARAS)と腎線維筋異形成(FMD)の2つの適応症によって引き起こされます。
当レポートは、世界の頸動脈および腎動脈ステント市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。
Not Applicable
Not Applicable
Carotid and Renal Artery Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Carotid and Renal Artery Stents market for the year 2020 and beyond. Three types of therapies are recommended for carotid stenosis. These therapies include medication, endovascular intervention, and endarterectomy.
Endarterectomy is recommended over stenting to patients who are suffering from stenosis (>70%) and have had symptoms for the last six months to a year. It is not recommended to individuals with 50% or less stenosis in the carotid artery. Endovascular therapy is a new option available to treat carotid stenosis. Endovascular treatment is a minimally invasive procedure using a stent to open the artery in the affected area. Whereas, RAS is primarily caused by two indications, Atherosclerotic Renal Artery Stenosis (ARAS) and Renal Fibromuscular Dysplasia (FMD).
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Carotid and Renal Artery Stents and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories , Hellman and Friedman LLC , Boston Scientific Corp , Silk Road Medical Inc , Medtronic Plc, Terumo Corp, Cook Group Inc, Biotronik SE & Co KG, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable